Results 141 to 150 of about 3,667 (197)

Acute Rickettsiosis Triggering <i>Plasmodium vivax</i> Relapse in a Returned Traveler: A Case Report and Clinical Review of Travel-Related Coinfections. [PDF]

Pathogens
Bagga R, Fuller C, Shahzad K, Bado E, Joshi J, Fernando D, Hempel A, Boggild AK.   +7 more
europepmc   +1 more source

Infections After International Travel: Relevant Diagnoses in Children and Adolescents. [PDF]

Dtsch Arztebl Int
Kotsias-Konopelska S, Thielecke M.
europepmc   +1 more source

Cutaneous Chikungunya in a Nonfebrile Traveler to Madagascar. [PDF]

Am J Trop Med Hyg
Alavian N, Zavala S, Rolfe R.
europepmc   +1 more source

Recurrent Malaria with <i>Plasmodium vivax</i>: A Case Report and Brief Review of the Literature. [PDF]

Trop Med Infect Dis
Andrejkovits ÁV, Pop AV, Fejér M, Gîrbovan EC, Coșeriu RL, Vintilă C, Văsieșiu AM.   +6 more
europepmc   +1 more source

Atovaquone-venturicidin A combination is synergistic against Plasmodium falciparum

Hauser D, Sax S, Keller S, Cal M, Kaiser M, Mäser P.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Atovaquone–Proguanil for Prophylaxis and Treatment of Malaria

Annals of Pharmacotherapy, 2003
OBJECTIVE: To review the currently available information on atovaquone–proguanil for treatment and prophylaxis of malaria. DATA SOURCES: A MEDLINE search was conducted from 1966 to February 2003 using key phrases Malarone, atovaquone ...
Fawziah Marra, Mary H H Ensom
exaly   +3 more sources

Atovaquone/proguanil for the prophylaxis and treatment of malaria

Expert Review of Anti-Infective Therapy, 2005
Increases in international travel and escalating drug resistance have resulted in a growing number of travelers at risk of contracting malaria. Drug resistance and intolerance to standard agents such as chloroquine, sulfadoxine/pyrimethamine and mefloquine has highlighted the need for new antimalarials.
Samir N Patel, Kevin C Kain
exaly   +3 more sources

Atovaquone/Proguanil Therapy forPlasmodium falciparumandPlasmodium vivaxMalaria in Indonesians Who Lack Clinical Immunity

Clinical Infectious Diseases, 2002
Thirty-eight of 295 subjects participating in a randomized, double-blind, placebo-controlled trial of the efficacy of daily administration of atovaquone/proguanil for malaria prevention developed malaria at some time during the 20-week prophylaxis period.
Jason D Maguire, Jeffrey D Chulay, Stephen L Hoffman   +2 more
exaly   +2 more sources

Efficacy of atovaquone-proguanil?

Lancet, The, 2001
Ashley Croft, Katie Geary, Liz Morgan
exaly   +3 more sources